Louis Metzger
CEO & Founder, dGenThera
Biotech Synthetic Biology Nuclear
About
Louis Metzger, PhD, is the Co-founder and CEO of dGenThera, a radiopharmaceutical startup that develops theranostics using novel halogen chemistry to treat solid tumors. With prior experience at Novartis Pharma and leadership roles in synthetic biology and gene therapy startups, he brings extensive expertise in biotechnology and pharmaceuticals. He is passionate about extending healthspan for cancer survivors by creating targeted radiotherapeutics that aim for long-term remission while minimizing damage to healthy tissues.
